International Journal of Applied Science - Research and Review Open Access

  • ISSN: 2394-9988
  • Journal h-index: 10
  • Journal CiteScore: 2.27
  • Journal Impact Factor: 1.33
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Differential methylation analysis in cleft lip and palate and its contribution to penetrance effects

European Conference on Agriculture, Horticulture & Epigenetics
February 25- 26, 2019 | Paris, France

Lucas Alvizi, Barbara Bischain, Xiayi Ke, Luciano Abreu Brito, Rimante Seselgyte, Gudrun E. Moore, Philip Stanier and Maria Rita Passos-Bueno

CEGH-CE-IB, Universidade de S�?£o Paulo, Brazil Institute of Child Health-University College of London, UK

Posters & Accepted Abstracts: Int J Appl Sci Res Rev

Abstract:

Cleft lip and/or palate (CL/P) is a common craniofacial congenital malformation, affecting 1 to 700 livebirth worldwide, with a multifactorial aetiology. Although several at-risk common alleles have been identified, they do not completely explain its high heritability (45% to 85%). We postulated that epigenetic factors as DNA methylation might contribute to this missing heritability. Using a methylome-wide association study in a Brazilian cohort (67 CL/P, 59 controls), we found 578 methylation variable positions (MVPs) significantly associated with CL/P and enriched in the “Regulation of Epithelial-to-mesenchymal transition” pathway. In an independent UK cohort (171 CL/P, 177 controls), we replicated 4 out of 11 tested MVPs. Epithelial-to-mesenchymal transition (EMT) is a key process during neural-crest cells formation as well as in palatal and lip fusion, in which cells from an epithelial state differentiate into a mesenchymal phenotype. CDH1, encoding E-cadherin, is a gene of importance during EMT and CDH1 pathogenic mutations have been associated to CL/P, with incomplete penetrance (~50%). Next, we quantified CDH1 promoter methylation levels in CDH1 mutation-positive families with incomplete penetrance. We found methylation levels to be significantly higher in the penetrant individuals. Finally, aiming to identify individual methylation differences, we used a different approach in which we compared each CL/P vs. all controls (1 CL/P vs. 59 controls) at the promoter and gene body level. Very promising results were obtained with this analysis, which showed individual methylation variation in genes already associated to CL/P and in new candidate genes. We are now validating those results in an independent cohort and using a dcas9-TET1 and dcas9-DNMT3A system for targeted demethylation and methylation respectively. Taken together, our results demonstrated the association of methylation at specific genomic sites and regions as contributing factors to CL/P and we suggest that altered DNA methylation may be a second hit contributing to penetrance.

Biography :

E-mail:

lucas.alvizi@gmail.com